Mark G. Erlander

15.8k citations
106 papers · 13.3k · 2 hit papers · h-index 52

Impact in

Papers in

    • Breast Cancer Treatment Studies 23
    • Cancer Genomics and Diagnostics 9
    • Cancer Diagnosis and Treatment 13

Mark G. Erlander

106 papers receiving 12.7k citations

Mark G. Erlander's Hit Papers

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms 1993 · 616 citations
6160+11+23Years since publication2505007501k

Peers

Mark G. Erlander
Comparison fields: 5 of 125
  • Cancer Research 3.2k
  • Cellular and Molecular Neuroscience 2.2k
  • Oncology 1.4k
  • Endocrine and Autonomic Systems 314
  • Developmental Neuroscience 166
Replace Keiichi I. Nakayama with:
Keiichi I. Nakayama Japan
Thomas N. Seyfried United States
Anders Nykjær Denmark
Masatoshi Hagiwara Japan
Jianming Xu United States
Kazuki Nakao Japan
Tod Smeal United States
David W. Rose United States
Ju Chen United States
Ronald Michael Lechan United States
Mark G. Erlander relative to Keiichi I. Nakayama Japan Keiichi I. Nakayama's profile →
Citations per field
00.5×2×2.9×
Keiichi I. Nakayama · 1×
Citations per year

Countries citing papers authored by Mark G. Erlander

Since Specialization
Citations

This map shows the geographic impact of Mark G. Erlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Erlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Erlander more than expected).

Fields of papers citing papers by Mark G. Erlander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Erlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Erlander. The network helps show where Mark G. Erlander may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark G. Erlander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark G. Erlander Line = papers co-authored together Mark G. Erlander links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Two genes encode distinct glutamate decarboxylases
Hit paper breakdown →
19911059
2 2004760
3 2003743
4 1999648
5
A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms
Hit paper breakdown →
1993616
6 1999612
7 2009522
8 1991410
9 1992407
10 1992389
11 2013322
12 2007308
13 1993260
14 2016258
15 2008257
16 2003243
17 1992230
18 1999230
19 2004226
20 1999223

About Mark G. Erlander

Mark G. Erlander is a scholar working on Cancer Research, Oncology, Cellular and Molecular Neuroscience, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 13.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Cancer Diagnosis and Treatment (13 papers), Neuroscience and Neuropharmacology Research (12 papers), Molecular Biology Techniques and Applications (10 papers), Gene expression and cancer classification (10 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Receptor Mechanisms and Signaling (7 papers). The work is most often cited by research in Cancer Research (3.2k citations), Cellular and Molecular Neuroscience (2.2k citations), Oncology (1.4k citations), Endocrine and Autonomic Systems (314 citations) and Developmental Neuroscience (166 citations). Mark G. Erlander has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Allan J. Tobin, Sophie Feldblum, Niranjala J.K. Tillakaratne, Dennis C. Sgroi, Allan J. Tobin, Xiaojun Ma, Timothy W. Lovenberg, Ranelle C. Salunga, Jayashree Pyati and Sandy J. Wilson. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Proceedings of the National Academy of Sciences, Breast Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact